Retinal Malady Classification using AI: A novel ViT-SVM combination architecture

Early and accurate classification of retinal diseases is critical to counter vision loss and for guiding clinical management of retinal diseases. In this study, we proposed a deep learning method for retinal disease classification utilizing optical coherence tomography (OCT) images from the Retinal OCT Image Classification - C8 dataset (comprising 24,000 labeled images spanning eight conditions). Images were resized to 224x224 px and tested on convolutional neural network (CNN) architectures: Xception and InceptionV3. Data augmentation techniques (CutMix, MixUp) were employed to enhance model generalization. Additionally, we applied GradCAM and LIME for interpretability evaluation. We implemented this in a real-world scenario via our web application named RetinaVision. This study found that Xception was the most accurate network (95.25%), followed closely by InceptionV3 (94.82%). These results suggest that deep learning methods allow effective OCT retinal disease classification and highlight the importance of implementing accuracy and interpretability for clinical applications.

Diabetic retinopathy (DR) is one of the main causes of impaired vision. A good and reliable automated grading system can make the screening process safer and more accurate. Because DR stages progress gradually, the task of grading disease severity naturally follows an ordinal structure in which neighboring classes share similar visual characteristics. In this study, ORViT-DR, a hybrid deep learning framework, is designed to improve DR grading from low-resolution retinal images. The proposed approach combines convolutional feature extraction with transformer-based global context modeling through a pre-trained ViT-Hybrid backbone, which integrates BiT-ResNetv2 with a Vision Transformer architecture. The approach is tested on the RetinaMNIST subset of the MedMNISTv2 dataset, which contains 28x28 retinal fundus images annotated with five levels of disease severity. To promote stable training and better feature learning, the training strategy applies progressive layer unfreezing, layer-wise learning rate decay, exponential moving average (EMA) parameter updates, and ensemble-based prediction during inference. Experimental results on the official RetinaMNIST test set show that the proposed method achieves 57.00% classification accuracy, along with a quadratic weighted kappa score of 0.5963 and a macro-F1 score of 0.4293. These results suggest that hybrid CNN-Transformer architectures can provide effective representations for ordinal retinal image analysis.

Modern deep learning offers powerful tools for automated retinal screening, but it remains unclear how different visual model families compare in realistic multi-disease settings and under domain shift. In this work, we benchmark twelve architectures across four model families: convolutional neural networks, vision transformers, hybrid CNN-transformer backbones, and vision-language models, using the Retinal Fundus Multi-disease Image Dataset (RFMiD). We evaluate two tasks: binary screening for any retinal disease and multi-label classification across 28 disease classes. Using standardized training, calibration, and evaluation protocols, we report AUC, F1, precision, recall, and sensitivity at a clinically relevant operating point with specificity near 80%. On RFMiD, all architectures perform well on binary screening, with AUC above 84%, but attention-based models perform best. SwinTiny and the hybrid CoAtNet0 and MaxViTTiny models achieve the strongest binary screening results and improve macro and micro F1 in the multi-label setting. Vision-language models, including CLIP ViT-B/16 and SigLIP-Base384, are competitive with CNN baselines but do not surpass the best transformer and hybrid backbones. In external validation on Messidor-2 for referable diabetic retinopathy, AUC ranges from 66.8% to 84.7%, with hybrid and transformer models again showing strong performance. These results provide a reproducible reference for model selection in multi-disease retinal screening and guide future automated screening tools for clinical deployment.